Video content has been blocked in accordance with your cookie settings. You can access this feature by accepting all cookies or adjusting your cookie settings below.
Elliot Hentov talks about the potential implications of Omicron’s emergence. Video (1:58)
The virus is back, or is it really?
It's been months since investors thought about COVID as a market driver, but the arrival of the Omicron variant does raise several questions. I'll make three quick points here.
The first is uncertainty. Uncertainty usually parallels volatility, and we should still continue to see more of that in the coming days and weeks as a variety of medical data comes to light. Some of it will be from labs, some of it from the real world. But a lot of it has the potential to push markets in different directions.
Given the sensitivity of the topic, the second point is risk. All in all, risks are clearly to the downside. Why? Well, in the best-case scenario, nothing changes. Omicron just, you know, the vaccine wall holds steady. It performs, and you basically have a continued, slow climb out of the pandemic, but the worst-case scenarios could be quite worse. It could lead to some regions of the world reimposing restrictions and curtailing economic activity, and therefore exacerbating the pandemic stress on the global economy.
And that leads me to point 3, which is policy support. It would certainly be weaker. We could not expect the same fiscal easing we had in the last 20 months, but more importantly, central bankers are fighting an enemy today named inflation and given inflationary levels where they are, monetary policy would certainly not be as supportive. And therefore Omicron needs to still be taken seriously. Even if initial signs are promising that the vaccines will hold.
The information provided does not constitute investment advice and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any investor’s particular investment objectives, strategies, tax status or investment horizon. You should consult your tax and financial advisor. All information has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. There is no representation or warranty as to the current accuracy, reliability or completeness of, nor liability for, decisions based on such information.
The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without State Street Global Advisors’ express written consent
This document may contain certain statements deemed to be forward-looking statements. Please note that any such statements are not guarantees of any future performance and that actual results or developments may differ materially from those projected in the forward-looking statements.
The views expressed in this material are the views of the author noted through the period ended 07 December 2021 and are subject to change based on material and other conditions. This document contains certain statements that may be deemed forward-looking statements.
Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected.
You should obtain and read a Key Investor Information Document and Prospectus relating to the SSGA Cash funds prior to investing. Further information, including the annual and semi-annual reports and the Key Investor Information Document and Prospectus describing the characteristics, charges, expenses and risks involved in your investments are available for residents of countries where SSGA cash funds are authorized for sale, at www.ssga.com/cash and from your local SSGA office or by calling +44 (0)20 3395 2333.
Investing involves risk including the risk of loss of principal. It is possible to lose money by investing in the funds.
Before investing, carefully consider a fund's investment objectives, risks, charges and expenses. Click the link to obtain a prospectus which contains this and other information, or by calling +44 (0)20 3395 2333, please read it carefully before investing.